Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127430341 | 12743034 | 1 | I | 201601 | 20160209 | 20160914 | 20160914 | PER | US-SIGMA-TAU US-2016STPI000097 | SIGMA TAU | 39.80 | YR | F | Y | 0.00000 | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127430341 | 12743034 | 1 | PS | MATULANE | PROCARBAZINE HYDROCHLORIDE | 1 | Oral | 200 MG, OTHER | U | B145022 | 16785 | 200 | MG | CAPSULE | |||||
| 127430341 | 12743034 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127430341 | 12743034 | 1 | Neoplasm malignant |
| 127430341 | 12743034 | 2 | Neoplasm malignant |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127430341 | 12743034 | Abdominal pain upper | |
| 127430341 | 12743034 | Asthenia | |
| 127430341 | 12743034 | Fatigue | |
| 127430341 | 12743034 | Myalgia | |
| 127430341 | 12743034 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127430341 | 12743034 | 1 | 20160122 | 0 |